Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study

References

• Aggarwal BB, Kumar A, Bharti AC. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363–98
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–18
   PubMed Web of Science ®Google Scholar
• Araújo J, Gonzalez-Mira E, Egea MA, et al. (2010). Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm 393:167–75
   PubMed Web of Science ®Google Scholar
• Arbiser JL, Klauber N, Rohan R. (1998). Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4:376–83
   PubMed Web of Science ®Google Scholar
• Battaglia L, Gallarate M. (2012). Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv 9:497–508
   PubMed Web of Science ®Google Scholar
• Bava SV, Puliappadamba VT, Deepti A, et al. (2005). Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-nB and the serine/threonine kinase Akt and is independent of tubulin polymerization. J Biol Chem 280:6301–8
   PubMed Web of Science ®Google Scholar
• Chan MM, Fong D, Soprano KJ, et al. (2003). Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agent. J Cell Physiol 194:63–70
   PubMed Web of Science ®Google Scholar
• Chow HHS, Chen Z, Matsuura GT. (1999). Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats. J Pharm Sci 88:754–8
   PubMed Web of Science ®Google Scholar
• Feng F, Zheng D, Zhang D, et al. (2011). Preparation, characterization and biodistribution of nanostructured lipid carriers for parenteral delivery of bifendate. J Microencapsul 28:280–5
   PubMed Web of Science ®Google Scholar
• How CW, Abdullah R, Abbasalipourkabir R. (2011). Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with polysorbate 20 and polysorbate 80. Afr J Biotechnol 10:1684–9
   Web of Science ®Google Scholar
• Jiang XG, Cui JB, Fang XL, et al. (1995). Toxicity of drugs on nasal mucocilia and the method of its evaluation. Acta Pharmacol Sin 30:848–53
   Google Scholar
• Joshi MD, Müller RH. (2009). Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 71:161–72
   PubMed Web of Science ®Google Scholar
• Kakkar WM, Schwabe K, Müller RH, Keck CM. (2013). Preservation of nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 76:56–67
   Google Scholar
• Li C. (2002). Poly (l-glutamic acid)–anticancer drug conjugates. Adv Drug Deliv Rev 54:695–713
   PubMed Web of Science ®Google Scholar
• Li L, Braiteh FS, Kurzrock R. (2005). Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104:1322–31
   PubMed Web of Science ®Google Scholar
• Liu CH, Wu CT. (2010). Optimization of nanostructured lipid carriers for lutein. Colloids Surf A: Physicochem Eng Asp 353:149–56
   Web of Science ®Google Scholar
• Liu D, Liu Z, Wang L, et al. (2011). Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces 85:262–9
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhang X, Wu H, et al. (2011). Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo. Drug Dev Ind Pharm 37:475–81
   PubMed Web of Science ®Google Scholar
• Mistry A, Stolnik S, Illum L. (2009). Nanoparticles for direct nose to brain delivery of drugs. Int J Pharm 379:146–57
   PubMed Web of Science ®Google Scholar
• Montenegro L, Campisi A, Sarpietro MG, et al. (2011). In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain. Drug Dev Ind Pharm 37:737–46
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–8
   PubMed Web of Science ®Google Scholar
• Nyström AM, Fadeel B. (2012). Safety assessment of nanomaterials: implications for nanomedicine. J Control Release 16:403–8
   Web of Science ®Google Scholar
• Obeidat WM. (2012). Investigation of temperature-induced physical instability of preserved coenzyme Q10-loaded (NLC): a comparative study at different temperatures. Afr J Pharm Pharmacol 6:2413–23
   Web of Science ®Google Scholar
• Pawar YB, Purohit H, Valicherla GR, et al. (2012). Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach. IntJ Pharm 436:617–23
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu J, Qiao H, et al. (2010). Formulation and optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology. Powder Technol 197:120–8
   Web of Science ®Google Scholar
• Zhao L, Feng S. (2010). Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies. J Pharm Sci 99:3552–60
   PubMed Web of Science ®Google Scholar